alexa
Reach Us +44-1625-708989
Editor - Jieh-Juen Yu | University of Texas at San Antonio | 19363

Journal of Infectious Disease and Pathology
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Jieh-Juen Yu

Jieh-Juen Yu
Jieh-Juen Yu
Assistant Professor of Research
University of Texas at San Antonio
USA
University of Texas at San Antonio

Biography

Dr. Jieh-Juen Yu, a Research Faculty at the University of Texas at San Antonio, United States, obtained his Ph.D. in Biological Science from the University of Texas at Austin. Dr. Yu is a mucosal immunologist and studies protective immunity against bacterial infections caused by Francisella tularensis, a potential biological weapon, and Acientobacter baumannii, an emerging agent of multi-drug resistant (MDR) hospital and community acquired and combat related infections. Dr. Yu has more than 20 years’ experience working with Biodefense and Emerging Infectious Diseases agents (Coccidioides and Francisella) in ABSL3 facility and his research on the vaccine development against coccidioidomycosis and tularemia had led to 3 awarded patents. During his research career, Dr. Yu has built his expertise on genetic manipulation of microorganism, protein characterization, mucosal immunology and vaccinology.

Research Interest

Bacterial pathogenesis, Immune response to bacterial infections, Vaccine development against bacterial pathogens.

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7
Top